| Lot ID | Purity | Net Content | Endotoxin | Sterility |
|---|---|---|---|---|
| GPV0600810261 | 99.556% | 66.78 mg (111.3%) | < 0.07 EU/mL | Pass |
GHKPV
GHKPV is a research blend combining 50 mg GHK-Cu with 10 mg KPV, bringing together two distinct peptides studied for regenerative signaling, tissue remodeling, and inflammatory-response pathways in preclinical research models.
Original price was: $60.00.$54.00Current price is: $54.00.
In stock
What is GHKPV?
GHKPV is a two-peptide research blend containing 50 mg GHK-Cu and 10 mg KPV per vial. The formulation combines a copper-binding tripeptide associated with tissue remodeling and regenerative signaling with a melanocortin-derived tripeptide studied for anti-inflammatory activity.
Research Interest
GHK-Cu has been investigated in skin, connective tissue, wound healing, fibroblasts, angiogenesis, and extracellular matrix research. KPV, the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone, has been studied primarily for its effects on inflammatory signaling, including NF-κB and cytokine pathways.
Complementary Research Rationale
The blend brings together two different areas of peptide research. GHK-Cu is primarily associated with remodeling, cellular repair signaling, and extracellular matrix regulation, while KPV has been investigated for its modulation of inflammatory responses. The combination itself has not been established as a clinically validated formulation, so evidence for the individual components should not be interpreted as direct evidence for the finished blend.
Composition
- GHK-Cu — 50 mg
- KPV — 10 mg
- Total peptide content — 60 mg

